NEVVI Medicare utilization intelligence

← back

KHORSAND-SAHBAIE, MASOUDMD NPI 1629066097 Clinician

Hematology-Oncology · ROSWELL, NM

Specialty Hematology-Oncology — from billed Medicare claims
In practice about 37 years since medical school (class of 1989, self-reported to CMS)
Location ROSWELL, NM · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 87 codes billed · 40,757 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026
MASOUD KHORSAND- SAHBAIE MD P A
2019–2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2017-01

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Included with Platform.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj
J0897 Injection, denosumab, 1 mg
36415 Insertion of needle into vein for collection of blood sample
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
80053 Blood test, comprehensive group of blood chemicals
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units
J2469 Injection, palonosetron hcl, 25 mcg
83615 Lactate dehydrogenase (enzyme) level
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
80061 Blood test, lipids (cholesterol and triglycerides)
84443 Blood test, thyroid stimulating hormone (tsh)
82570 Creatinine level to test for kidney function or muscle injury
83036 Hemoglobin a1c level
81001 Manual urinalysis test with examination using microscope, automated
80069 Kidney function blood test panel
82728 Ferritin (blood protein) level
J9190 Injection, fluorouracil, 500 mg
83540 Iron level
83550 Iron binding capacity
84439 Thyroxine (thyroid chemical), free
82306 Vitamin d-3 level
96413 Administration of chemotherapy into vein, 1 hour or less
J2919 Injection, methylprednisolone sodium succinate, 5 mg
82043 Urine microalbumin (protein) level
82784 Gammaglobulin (immune system protein) measurement
84156 Total protein level, urine
96375 Injection of additional new drug or substance into vein
84153 Psa (prostate specific antigen) measurement, total
A9595 Piflufolastat f-18, diagnostic, 1 millicurie
84550 Uric acid level, blood
83735 Magnesium level
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
83970 Parathormone (parathyroid hormone) level
78815 Nuclear medicine study from skull base to mid-thigh with ct scan
82378 Carcinoembryonic antigen (cea) protein level
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries
96372 Injection of drug or substance under skin or into muscle
80048 Blood test, basic group of blood chemicals (calcium, total)
86140 Measurement c-reactive protein for detection of infection or inflammation
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit)
96415 Administration of chemotherapy into vein, each additional hour
96417 Administration of additional new drug or substance into vein, 1 hour or less
84481 Thyroid hormone, t3 measurement, free
85045 Red blood count, automated test
J1200 Injection, diphenhydramine hcl, up to 50 mg
84100 Phosphate level
82607 Cyanocobalamin (vitamin b-12) level
85610 Blood test, clotting time
96523 Irrigation of implanted venous access drug delivery device
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
36591 Collection of blood sample from implanted device
71250 Ct scan of chest without contrast
96361 Infusion into a vein for hydration, each additional hour
85652 Red blood cell sedimentation rate, to detect inflammation, automated
71046 X-ray of chest, 2 views
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
J3490 Unclassified drugs
74177 Ct scan of abdomen and pelvis with contrast
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion
71260 Ct scan of chest with contrast
82746 Folic acid level, serum
77080 Dxa bone density measurement of hip, pelvis, spine
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l
84403 Testosterone (hormone) level, total
96360 Infusion into a vein for hydration, 31-60 minutes
85007 Microscopic examination for white blood cells with manual cell count
85027 Complete blood cell count (red cells, white blood cell, platelets), automated test
G0103 Prostate cancer screening; prostate specific antigen test (psa)
85055 Reticulated (young) platelet measurement
86301 Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9
74176 Ct scan of abdomen and pelvis without contrast
99211 Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional
80076 Liver function blood test panel
82550 Creatine kinase (cardiac enzyme) level, total
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
76770 Complete ultrasound scan behind abdominal cavity
87635 Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen
A9503 Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
78306 Nuclear medicine study of bone and/or joint whole body
82248 Bilirubin level, direct
87324 Detection test by immunoassay technique for clostridium difficile toxins (stool pathogen)
87502 Detection test by nucleic acid for multiple types influenza virus
86431 Rheumatoid factor level

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.